haloperidol has been researched along with Developmental Psychomotor Disorders in 19 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 7.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| "This case report describes a 15-year-old male patient with spastic diplegic cerebral palsy, Gross Motor Function Classification System Level III, who developed severe new cognitive and motoric impairments after the administration of haloperidol." | 3.79 | Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report. ( Gelfius, CD; Mortimer, D; Potts, MA, 2013) |
| "We investigated whether 50-kHz USV playback ameliorates psychomotor deficits induced by haloperidol in a sub-chronic dosing regimen." | 1.56 | Playback of 50-kHz ultrasonic vocalizations overcomes psychomotor deficits induced by sub-chronic haloperidol treatment in rats. ( Melo-Thomas, L; Müller, CP; Schwarting, RKW; Tonelli, LC; Wöhr, M, 2020) |
| "When morphine was injected 4 h after AMT, a mutual potentiation of the two drugs on hypokinesia and catalepsy was observed, although previous biochemical measurements had shown no effect of morphine on CA depletion under these conditions." | 1.26 | AMT catalepsy and hypokinesia: interaction with morphine and cocaine. ( Ayhan, H; Papeschi, R; Theiss, P, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Melo-Thomas, L | 1 |
| Tonelli, LC | 1 |
| Müller, CP | 1 |
| Wöhr, M | 1 |
| Schwarting, RKW | 1 |
| Mortimer, D | 1 |
| Gelfius, CD | 1 |
| Potts, MA | 1 |
| Bischoff, A | 1 |
| Galderisi, S | 1 |
| Mucci, A | 1 |
| Bitter, I | 1 |
| Libiger, J | 1 |
| Bucci, P | 1 |
| Fleischhacker, WW | 1 |
| Kahn, RS | 1 |
| Soyka, M | 1 |
| Winter, C | 1 |
| Kagerer, S | 1 |
| Brunnauer, M | 1 |
| Laux, G | 1 |
| Möller, HJ | 1 |
| Putzhammer, A | 1 |
| Perfahl, M | 1 |
| Pfeiff, L | 1 |
| Ibach, B | 1 |
| Johann, M | 1 |
| Zitzelsberger, U | 1 |
| Hajak, G | 1 |
| Schmidt, LG | 1 |
| Grohmann, R | 1 |
| Helmchen, H | 1 |
| Langscheid-Schmidt, K | 1 |
| Müller-Oerlinghausen, B | 1 |
| Poser, W | 1 |
| Rüther, E | 1 |
| Scherer, J | 1 |
| Strauss, A | 1 |
| Wolf, B | 1 |
| Heinz, A | 1 |
| Knable, MB | 1 |
| Coppola, R | 1 |
| Gorey, JG | 1 |
| Jones, DW | 1 |
| Lee, KS | 1 |
| Weinberger, DR | 1 |
| O'Keeffe, ST | 1 |
| Lavan, JN | 1 |
| White, JH | 1 |
| O'Shanick, G | 1 |
| ter Haar, HW | 1 |
| Carter, RG | 1 |
| Papeschi, R | 1 |
| Theiss, P | 1 |
| Ayhan, H | 1 |
| Weihmuller, FB | 1 |
| Hadjiconstantinou, M | 1 |
| Bruno, JP | 1 |
| Flügel, KA | 1 |
| Gill, J | 1 |
| de L Horne, DJ | 1 |
| Tobin, JM | 1 |
| Brousseau, ER | 1 |
| Lorenz, AA | 1 |
| Vallecorsi, G | 1 |
| Bavazzano, A | 1 |
| Greger, J | 1 |
| Glitschka, A | 1 |
| Müller, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia[NCT03775564] | 60 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for haloperidol and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzot | 2013 |
Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
Topics: Adult; Antipsychotic Agents; Attention; Automobile Driving; Case-Control Studies; Female; Haloperido | 2005 |
Performance of diadochokinetic movements in schizophrenic patients.
Topics: Analysis of Variance; Antipsychotic Agents; Biomechanical Phenomena; Case-Control Studies; Dose-Resp | 2005 |
The relief of restlessness in the elderly.
Topics: Activities of Daily Living; Aged; Chlormethiazole; Clinical Trials as Topic; Cognition; Confusion; D | 1977 |
Clinical evaluation of haloperidol in geriatric patients.
Topics: Aged; Clinical Trials as Topic; Dementia; Haloperidol; Humans; Psychomotor Disorders; Psychopharmaco | 1970 |
14 other studies available for haloperidol and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Playback of 50-kHz ultrasonic vocalizations overcomes psychomotor deficits induced by sub-chronic haloperidol treatment in rats.
Topics: Acoustic Stimulation; Animals; Disease Models, Animal; Dopamine Antagonists; Exploratory Behavior; H | 2020 |
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine | 2013 |
[Acutely confused old man].
Topics: Acute Disease; Aged; Antipsychotic Agents; Benzodiazepines; Butyrophenones; Confusion; Haloperidol; | 2010 |
Adverse drug reactions. An epidemiological study at psychiatric hospitals.
Topics: Adult; Amitriptyline; Drug Evaluation; Female; Germany, West; Haloperidol; Hospitals, Psychiatric; H | 1984 |
Psychomotor slowing, negative symptoms and dopamine receptor availability--an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzamides; Brain; Dopamine Antagonists; Haloperidol; Hu | 1998 |
Clinical significance of delirium subtypes in older people.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Haloperidol; Humans; Prospective Studies; P | 1999 |
Juvenile manic-depressive illness.
Topics: Adolescent; Affective Symptoms; Antipsychotic Agents; Bipolar Disorder; Child Behavior Disorders; Er | 1977 |
Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient.
Topics: Acute Disease; Adolescent; Adult; Basal Ganglia Diseases; Conflict, Psychological; Female; Hallucina | 1977 |
AMT catalepsy and hypokinesia: interaction with morphine and cocaine.
Topics: Animals; Body Temperature; Brain Chemistry; Catalepsy; Catecholamines; Cocaine; Drug Interactions; D | 1976 |
Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cold Temperat | 1988 |
[Treatment of acute emotional disturbances].
Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Chlorpromazine; Chlorprothixene; Diazepam; Family Char | 1974 |
Psychological testing in depressive illness. I. Psychomotor performance.
Topics: Adult; Bipolar Disorder; Depression; Diagnosis, Differential; Female; Haloperidol; Humans; Male; Mid | 1974 |
[Haloperidol in the treatment of mental confusion in the aged].
Topics: Aged; Cognition Disorders; Dementia; Female; Haloperidol; Humans; Male; Psychomotor Disorders | 1971 |
[On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Child; Depression; Depressive Disorder, Major; Extrapyrami | 1968 |